For over 20 years, the Trust has supported world-leading translational research projects through the Sir Jules Thorn Award. The Award provides a grant of up to £1.7 million to support a five-year programme of translational biomedical research selected following a competition among applicants sponsored by the UK’s leading medical schools and NHS organisations. UK medical schools and NHS organisations are normally able to submit one application annually, selected following an internal competition.
How to Apply
Preliminary applications for 2026 are open and can be submitted here. The preliminary application will be available until Monday, 15 December 2025, at noon UTC. Please note that no late submissions will be accepted.
Timings
Applications for the 2026 Sir Jules Thorn Award are now open. Preliminary applications are due on Monday, 15 December 2025, at noon UTC.
Information about the selection process for the Award is set out in the guidance below for the competition.
The AMRC accredits the Trust’s peer review process.
1. Clear alignment with the Trust’s mission: improving health, care, support for serious illness or disability
Whether biomedical research, care-improvement, disability support, palliative care, or mental-health support — the proposed work must aim at meaningful benefit for people living with illness, chronic conditions or disability, or their carers/families.
The linkage must be explicit: the proposal should clearly state how the work will improve care, quality of life, treatment, support or services for intended beneficiaries.
2. Translational / Practical Impact (for Research or Health-Care Programmes)
For research grants: the Trust emphasizes translational biomedical research — not just basic science, but work likely to lead to improved diagnosis, therapies, or patient benefit.
For infrastructure or care-improvement grants: projects should demonstrate how equipment, facilities or service changes will accelerate research or improve care delivery for patients.
3. Institutional Quality, Capacity & Commitment (for Large Grants)
For large grants (e.g. Biomedical Research Award), the applicant must come from a UK medical school or NHS organisation; only one application per institution per year is allowed — indicating strong internal vetting and institutional competition.
The institution must demonstrate appropriate research infrastructure, support, and ability to sponsor/host the research if clinical/translational trials are involved.
The Principal Investigator should be early in an established academic-research career (i.e. promising mid-career PIs), with prior track record and capacity to dedicate sufficient time (≥ 50% time commitment).
4. Well-Defined, Feasible, Impact-Oriented Plans
Proposals need clear hypotheses or objectives, well-articulated plans for translation to patient benefit, and demonstration of expected outcomes.
For equipment/infrastructure grants: clear justification on how the equipment or facility will accelerate research or improve care outcomes.
5. Focus on Unmet Needs or Areas of High Need / Serious Illness / Disability / Vulnerability
The Trust tends to prioritise projects addressing serious, life-limiting, chronic illnesses; disabilities; palliative care; mental health; unmet health/care gaps.
For small-grant programmes (Ann Rylands), they favour charities where health-care support is core, with robust governance, clarity of beneficiary group, and demonstrable need/value for money.
6. Organisational Stability and Proper Governance (especially for Small-Charity Applications)
For small-charity applications: eligible charities must be registered, have been in existence for at least 3 years, have annual income between £100,000 and £2 million, and have adequate financial controls/reserves (free reserves less than 12 months expenditure).
Excellent governance, demonstrated safeguarding, financial transparency, and capacity to deliver are required.
7. Value-for-Money, Realistic Budget, & Sustainable or Scalable Impact (Where Relevant)
Especially for small-donation grants: the Trust expects value for money — small injections of funds leading to meaningful outcomes, not one-off, expensive events.
For larger grants (infrastructure, research): justified budget, with clear link to outcomes, and capacity for follow-up or sustainability efforts.
8. Transparency, Ethical Standards & No Profit Motive
The Trust’s charitable status prohibits grants that contribute (even indirectly) to commercial profit for manufacturers. Projects with potential commercial benefit must avoid commercial sponsorship or ensure transparency.
For research or care projects involving patients: ethics/oversight, open data or open-access publication plans (especially for biomedical research) are expected.
If you plan to apply to the Sir Jules Thorn Charitable Trust — for research, infrastructure, care innovation, or small-charity support — here are strategic take-aways:
Ensure your project clearly addresses a real health, disability, chronic illness or care need (not just academic interest).
Match your proposal to the right grant programme: large translational research → Biomedical Award; equipment/infrastructure needs → Infrastructure Fund; care-service improvements → Innovation & Care Fund; small-charity support → Ann Rylands.
For large grants: secure institutional backing, ensure your role/time commitment aligns (≥50 %), and that your institution nominates the proposal (only one per institution).
For small-charity grants: verify your organisation meets eligibility — registered, 3+ years old, proper income/reserve range, good governance.
Design clear, feasible, and impact-oriented proposals — with realistic timelines, measurable outcomes, and value-for-money.
Avoid conflicts with commercial profit: make sure the project isn’t structured to benefit a manufacturer or company commercially (the Trust prohibits this under its charitable status).
For research: plan for transparent dissemination (open-access publication), ethical oversight, and long-term benefit to patients.
For care or service innovations: consider scalability, sustainability, and how the intervention will improve care for people with serious/chronic illness or disability.
Applications for the Sir Jules Thorn Award are welcome from UK medical schools and NHS Organisations, with only one application allowed per eligible institution/organisation. The research must have a justifiable claim to be at the leading edge of international science and must be led by a clearly identified Principal Applicant of outstanding quality in the early years of an established research and academic career.
3. Applications for the Award are open to UK medical schools and NHS organisations. Each eligible institution/organisation may only submit one application and will therefore need to select the proposal which is put forward. The Trust expects this selection to be made following an internal competition. The Head of the Medical School, Dean of Research or other appropriate person will need to provide a letter of support with the application, explaining how and why the proposal was selected for submission
4. Where a medical school and affiliated NHS organisation both have a prospective proposal, they must coordinate the selection process to decide which one should be submitted.
5. The submitting institution/organisation must be able to demonstrate:
6. The proposal must be led by a single, clearly identified Principal Applicant of outstanding quality in the early years of an established research and academic career. The Trust is flexible in defining this and acknowledges that exceptional researchers may not follow a conventional career path or may have taken time away from research for professional or personal reasons.
7. Candidates will be expected to demonstrate a strong track record of independent research, having served as Principal Investigator for one or more research grants supported by competitive, peer-reviewed funders. Successful candidates will also typically have held
8. There may only be one Principal Applicant per application.
9. Institutions/organisations should note that the Trust will not use the Award to support senior researchers who are already well-established in a professorial post or candidates whose research programme has already secured substantial ongoing funding.
10. The work set out in the proposal must be a major commitment for the Principal Applicant, comprising at least 50% of their overall time. Where the Principal Applicant holds an existing award from another funder, the institution/organisation must verify in its letter of support that the terms of that other funding are consistent with the 50%-time commitment required by the Award.
11. The Award may not be used to meet the salary costs of the Principal Applicant, who should be in an institutionally-funded post for the duration of the grant.
12. Please also note that the Trust will not support applications that are to supplement an existing project supported by other funding bodies, or to cover expenditure already incurred. Applications submitted concurrently to other funders will be accepted, but subsequent short-listing by the Trust would be conditional upon any such applications being withdrawn unless the Trust agrees otherwise. Any related applications must be noted in the application form.
13. The Trust’s charitable status does not permit the provision of a grant which might, whether directly or indirectly, contribute to a commercial profit for a manufacturer. An application cannot, therefore, be considered where a manufacturer is supplying a cash grant, equipment, materials, drugs, etc., at no cost, whether express or implied, for commercial use of the findings of the project.
Sponsor Institute/Organizations: Thorn (Sir Jules) Charitable Trust
Sponsor Type: Corporate/Non-Profit
Address: 24 Manchester Square London W1U 3TH T: 020 7487 5851 E: info@julesthorntrust.org.uk
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 15, 2025
Dec 15, 2025
$2,261,000
Affiliation: Thorn (Sir Jules) Charitable Trust
Address: 24 Manchester Square London W1U 3TH T: 020 7487 5851 E: info@julesthorntrust.org.uk
Website URL: https://julesthorntrust.org.uk/programmes/medical-research/the-sir-jules-thorn-award-for-biomedical-research/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.